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Abstract 
Using the field of direct-to-consumer genetic tests as a case in
point, this paper argues against the misuse of the term empowerment,
and calls for a regulation of its usage. The misleading assumption
under certain current usages of the concept of empowerment is that it
is enhanced by the provision of health information. While the informa-
tion-empowerment correlation is misleading, if not wrong, the feeling
of being empowered imposes an increasing burden of critical thinking
on those people (patients and consumers) who have to evaluate that
information and act for the benefit of their health.   
Introduction
As far as the healthcare field is concerned, we live nowadays an age
characterized by the ideology of empowerment. Empowerment, con-
ceived both as an outcome and as a process, refers to the acquisition
of knowledge and skills to master our own health, and to act in deci-
sion-making that is beneficial for the enhancement of our health.1
As a reflection of this claim of empowerment, we also live in the so-
called information age, which is more or less implicitly characterized
by the idea that the empowerment of patients and consumers is
enhanced by the provision of health information. The more informa-
tion about health-related topics people receive, the more effective play-
ers they become in the critical thinking process leading to health deci-
sions.2
This, for example, is the main argument put forward by the adver-
tisers of prescription medicines or Direct-To-Consumer (DTC)
Advertising. As they claim, pharmaceutical companies have more accu-
rate, balanced and scientifically-based information than any other
sources. As such, they are in an exclusive position to provide people
with adequate information on the safe use of medication, and to cre-
ate effective knowledge for evaluating the benefits and risks of drug
products, and generally in helping people manage their health
autonomously.3
Assuming the information-empowerment correlation, however, is
misleading, if not wrong. As Schulz and Nakamoto claim,4 the utility of
health information depends on the recipient’s background skills in
making effective use of that information. One of the key mediators
between information and empowerment is people’s health literacy.
Health literacy, in its comprehensive meaning, includes - alongside
traditional reading and numeracy skills - the ability to select the right
information, assess it critically and optimally apply it in the context of
individual life and existence.5,6 So, in order to make sense of the claim
Medicine X is used by millions with disease Y, which is often found in
DTC adverts, consumers must be skillful in finding the potential falla-
cy known as hasty generalization: although a treatment is used by X
people, how many of them get better? And even if it’s a lot, it might still
not be good for me. The risk of not thinking that critically is that con-
sumers might overestimate the benefits of a medicine and ignore all
the negative consequences.3
By drawing from the field of online selling of genetic tests, this
paper shows that online health marketing (intentionally or uninten-
tionally, but explicitly) uses the concept of empowerment to market
products, and concludes that there is the need for re-calibration of the
use of this concept at the policy level.   
Materials and Methods
A systematic World Wide Web search was carried out using the
Google and Yahoo! search engines to identify websites that sell genet-
ic tests DTC. To identify other websites of interest, a bibliographical
search was conducted on PubMed. Genetic testing was categorized as
non-health-related when websites offered parentage confirmation,
identity testing, genealogy testing, DNA banking and genetic match-
ing, and health-related when they offered genetic information related
to a consumer’s current or future health status. We only selected web-
sites selling health-related tests, including ones for predicting suscep-
tibility to future disease or diet-related disease (susceptibility genetic
testing/nutrigenetics), and for predicting how individuals may respond
to a particular drug treatment (pharmacogenetic tests) (Figure 1). 
Sites were excluded if: i) they offered a service that was only avail-
able to physicians or for clinical laboratory use; ii) they only sold non-
health-related genetic tests; iii) they did not sell online; and iv) they
required a medical prescription in order to buy the test. 
The selected websites were coded using an ad hoc codebook and the
content categories were analysed according to the Content Analysis
method7 in January 2011. In addition to other characteristics, the
analysis focused on the types of genetic test, the related information
Significance for public health
By conducting a content analysis of websites offering DTC susceptibility
genetic tests, this study aims to offer a critical contribution to the debate
regarding the possible implications on public health of this type of test.
Impact on the demand for healthcare services could be possible due to the
lack of adequate and regular genetic counselling and difficulty in interpret-
ing the significance of test results.  Misuse of the concept of empowerment
associated with emphasis on the role of genetic profile in the development
of a disease could lead to a misunderstanding of how prevention should be
carried out.  It is therefore important to underline the need to improve the
ability of potential consumers to select the right information, assess it criti-
cally and apply it optimally in the context of individual health promotion.
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and the types of offer, including the selling arguments, namely the
statements displayed by the websites to encourage users to purchase
tests.
Results
A total of 30 websites offering DTC genetic testing were found
(Appendix Table 1).
Genetic tests for susceptibility to cardiovascular disease were the
most frequent on offer (63%), as shown in Figure 2. 
Seventy percent of the websites clearly stated that susceptibility
genetic testing was not aimed at diagnosing disease. The purpose of
testing declared by the companies emphasized the risk assessment in
the majority of them (50%) in addition to genetic predisposition to
developing a disease (43% of the websites). Thirty percent of the web-
sites highlighted the issue of prevention. 
Consumers would receive their test results via a personal online
account (33%), ordinary mail (30%), e-mail (20%) or personal commu-
nication (3%); not specified in the rest (23%). Only three companies
(10%) required the results to be sent to the consumer’s general practi-
tioner, although 84% encouraged consumers to contact their physician
if they had any questions or concerns about their health status or inter-
pretation of the results. Fifty percent of the websites offered pre- and/or
post-test counselling. Counselling was performed mainly by telephone
(60%) and e-mail (13%); unspecified in the rest (27%). The service
was performed without an additional fee for consumers by 11 compa-
nies (73%), with a fee in 3 (20%) and unspecified in one (7%). 
Only 9 websites (30%) mentioned specific risks relating to testing.
In particular, genetic discrimination in 5 websites, potential for emo-
tional and psychological effects in 6, legal, familial or financial implica-
tions in 4 and false reassurance in 2. 
Patient empowerment was the most frequently used selling argu-
ment (70%), framed in sentences including: a. taking care of yourself
now is vital; b. past generations don’t have an advantage like this - we
are really fortunate; c. your doctor could be sure of giving you the best
treatment measurement; d. you are responsible for your health and one
and only one life; e. you can predict your body health; f. knowing factors
like your possible inherited disease susceptibility is something you
want to know; g. you can stop feeling the uncomfortable fear about
making your own health-related decisions; h. protect yourself now; i.
the right knowledge about your inherited genes, j. you want to be sure
you are doing everything you can to stay healthy; k. you want to be able
to work well with your doctor and take the guesswork out of it.
Other selling arguments were: the availability of a registered and
fully accredited clinical laboratory (37%), assurance of confidentiality
(33%), short time for testing process and despatch of the results (30%),
special offer (20%) and positive experience from customers (20%).
Discussion
In recent years, the range of companies involved in the DTC genetic
test market has been growing in parallel with the public interest in
DTC genetic testing.8,9 But what kind of knowledge are these websites
offering to consumers? 
They emphasize acquiring knowledge of the risks. The main purpose
of testing declared by the companies is to get an overall picture of the
personal health risk via a genetic profile, allowing preventive measures
to be taken. The majority of websites declared that genetic test results
Covolo et al.
Figure 1. Criteria of websites selection.
Figure 2. Type of
genetic tests offered.
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give an estimate of the predictive risk of disease or response to a drug;
however, companies rarely required a physical health examination or
completion of a health and lifestyle questionnaire prior to purchase of
the test and only half of them offered a counselling service. Risk
assessment based on genetic profile is correct when genetic predispo-
sition is the only risk factor for a disease. When talking about a com-
mon disorder, lifestyle and environmental factors should be taken into
consideration.10,11 Any test results could therefore be misleading since
the estimated risk may be accurate on average, but very inaccurate for
an individual.12 The evidence is that, although many of the assessed
websites mentioned the role of the environment on disease risk, they
still gave more emphasis to the role of genetics. One of the websites,
for example, reports the influence of environment versus genes for
each common disease tested for, but the first statement that a con-
sumer reads when visiting the health page is: Your disease risk is
impacted by your genetics.13 Still, this is not the whole story. 
Genome-based prediction of common diseases is still not informa-
tive, with little predictive power, despite increasing developments in
genomic research.14 There are as yet no common criteria for establish-
ing which genetic markers should be used for assessing the risk for a
particular disease. It is therefore not surprising that there are differ-
ences in the results given by different companies for the same genetic
test;15 and the primary source of discrepancy in disease-risk prediction
across companies was the variation in the selection of genetic markers.
Information and empowerment are not directly proportional. But
when the information is incomplete, as in the case of the websites
analysed in this study, either the person is competent in assessing its
meaning or implication, or the risk of generating wrong knowledge is
high. In this context the emphasis on genetic profile’s role in the devel-
opment of a disease could lead people to abandon all preventive meas-
ures – such as stopping smoking and losing weight – that have proven
successful and are likely to be broadly beneficial in relation to many
diseases. Alternatively an adoption of an unnecessary preventive meas-
ure could be also possible in a case of a false positive test result.
A study by McGuire et al.16 on social networkers’ attitude toward
direct-to-consumer personal genome testing led to important findings
that are worth presenting here. Despite the fact that the average web-
site denies the diagnostic power of its tests, 38% of respondents
(n=1087) who would consider using personal genome testing inter-
preted the results as a medical diagnosis. Of those, 60% who actually
used the website still considered the results to be a medical diagnosis.
They also anticipated that this testing would influence their future
healthcare decisions. Fifty-three percent of the respondents declared
that personal genomic testing increases individuals’ control over their
health and 74% would consider testing someone other than them-
selves. This result is consistent with data reported by C.S. Mott
Children’s Hospital showing that 53%17 of the parents interviewed were
interested in personal genetic testing for their children. 
Perceived knowledge and the feeling of being empowered in terms of
information assessment are, to a significant extent,  directly propor-
tional. Indeed, in the study by McGuire et al., 46% of the participants
claimed to know enough about genetics to understand the results. Forty
percent said they would use genetic testing to learn about their genet-
ic make-up without having to go through a physician.16
Health communication strongly advocates the need to tailor informa-
tion in order to present contents that match individuals’ educational,
psychological and cultural levels and their characteristics. Online sell-
ing companies still play on generic concepts which, being socially
appealing, influence the formation of a positive attitude towards their
products. Among these concepts, empowerment is a strong one. In the
context of empowerment, the benefits of spreading health information
seem to be negatively counter-balanced by the burden of critical think-
ing skills imposed on individuals who have to evaluate that informa-
tion. If, in the last ten years, much institutional and academic effort
has been made to highlight all the skills that an empowered consumer
should have, it is probably time to start thinking how to build these
skills in the public at large. Of course, this is a question that involves
educational efforts beyond the healthcare context, and it is still very
speculative in nature.
A paper published by Bowen et al. back in 200518 argued in favour of
better regulation of the marketing of genetic tests. It is difficult to con-
trol the virtual world of the internet and the types of website that
appear there on a daily basis. Yet it is undoubtedly time to speak up
about the side-effects of the instrumentalisation of the concept of
empowerment, and to regulate at least its usage. We have, here, a con-
cept that is still too vague and still insufficiently operational. Overall,
we wonder if, where and how the term empowerment should be used in
the current healthcare context, and we fear that until the myth of the
relationship between health information and autonomous decision-
making is alive these questions will not receive clear answers.
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